Daiichi-Sankyo (Japan)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi-Sankyo (Japan), Japan, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
52%
Total
Publications
6.3K
Total Open
Publications
3.3K
Total
Citations
209K
Open Access
Percentage
52%
Total
Publications
6.3K
Total Open
Publications
3.3K
Total
Citations
209K
Breakdown
Publisher Open
25%
Both
21%
Other Platform Open
6%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 30%
876
Hybrid 25%
723
No Guarantees 45%
1.3K
Other Platform Open
Domain 71%
1.2K
Institution 43%
740
Other Internet 17%
297
Preprint 4%
64
Public 3%
47
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.2K |
doaj.org OAI-PMH Repository | Institution | 403 |
DOI | Other Internet | 223 |
Unknown Repository | Other Internet | 86 |
National Institute of Informatics | Institution | 84 |
Figshare | Public | 45 |
Royal Netherlands Academy of Arts and Sciences | Institution | 43 |
Europe PMC | Domain | 41 |
Research Square | Preprint | 26 |
California Digital Library | Institution | 26 |